Ireland
# |
Name |
EBITDA |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 1.34 B
|
Sept. 30, 2024 | USD 218.34 | -1.05% |
|
Ireland |
|
2 |
USD 1.11 B
|
March 31, 2024 | USD 68.28 | -1.59% |
|
Ireland |
|
3 |
USD 819.30 M
|
Dec. 31, 2023 | USD 132.73 | -0.59% |
|
Ireland |
|
4 |
USD 525.00 M
|
Dec. 31, 2023 | USD 24.91 | -0.08% |
|
Ireland |
|
5 |
USD 21.74 M
|
Dec. 31, 2023 | USD 69.53 | -3.81% |
|
Ireland |
|
6 |
USD -34.58 M
|
Dec. 31, 2023 | USD 1.60 | 1.91% |
|
Ireland |
|
7 |
USD -149.12 M
|
Dec. 31, 2023 | USD 7.90 | 2.73% |
|
Ireland |
The Personal Care company in Ireland with the highest EBITDA is STERIS plc (NYSE: STE) at USD 1.34 B.
The Personal Care company in Ireland with the lowest EBITDA is Avadel Pharmaceuticals plc (NasdaqGM: AVDL) at USD -149.12 M.
The top 10 Personal Care companies in Ireland by EBITDA are STERIS plc, DCC plc, Allegion plc, Perrigo Company plc, Cosmo Pharmaceuticals N.V., Iterum Therapeutics plc and Avadel Pharmaceuticals plc.
The bottom 10 Personal Care companies in Ireland by EBITDA are Avadel Pharmaceuticals plc, Iterum Therapeutics plc, Cosmo Pharmaceuticals N.V., Perrigo Company plc, Allegion plc, DCC plc and STERIS plc.